Michael Schelle
Executive Vice President
Michael Schelle is an accomplished biotech executive with over 15 years of experience driving innovation and operational excellence in the life sciences industry. As the Executive Vice President at Remedy Plan Therapeutics, he oversees key strategic and operational initiatives, leveraging his deep expertise in product research, commercialization, and corporate strategy.
Professional Overview
Michael is a versatile leader with a proven track record of success in both established organizations and early-stage startups. He specializes in guiding biotech companies through critical growth phases, from new product development to efficient operations and impactful commercialization.
Experience Summary
Current Role
As the Executive Vice President at Remedy Plan Therapeutics, Michael is responsible for spearheading the company's strategic direction and overseeing its day-to-day operations. He plays a pivotal role in shaping the organization's product pipeline, driving collaboration between research, development, and manufacturing teams, and ensuring seamless execution across all business functions.
Under Michael's leadership, Remedy Plan Therapeutics has achieved several key milestones, including the successful launch of two novel therapeutics and the expansion of the company's global footprint. His strategic vision and operational expertise have been instrumental in positioning the organization as a leader in the biotech industry.
Career Progression
Prior to joining Remedy Plan Therapeutics, Michael held various leadership roles at Acrigen Biosciences, where he served as the Vice President of Research and Operations and the Head of Operations and Corporate Strategy. In these positions, he was responsible for driving the company's research and development initiatives, optimizing operational efficiency, and developing long-term corporate strategies.
Earlier in his career, Michael made significant contributions as the New Product Innovation and Commercialization Lead and the Director of Product Research and Analytics at Ripple Foods, a pioneering plant-based food company. He also gained valuable experience as a Senior Scientist at DuPont Industrial Biosciences, where he contributed to the development of innovative biobased solutions.
Academic Background
Michael holds a Ph.D. in Chemistry from the University of California, Berkeley, where he specialized in advanced materials and biocatalysis. His academic achievements, including several peer-reviewed publications and research grants, have reinforced his deep understanding of the scientific foundations underlying the biotech industry.
Areas of Expertise
- Biotech product research and development
- Operational excellence and process optimization
- Corporate strategy and new business development
- Regulatory compliance and quality assurance
- Team building and collaborative leadership
Professional Impact
Throughout his career, Michael has demonstrated a consistent track record of driving transformative change and delivering measurable results. His contributions have included the successful commercialization of multiple novel therapeutics, the implementation of lean manufacturing practices that improved operational efficiency by 25%, and the establishment of strategic partnerships that expanded the reach of his organizations.
Conclusion
With his extensive experience, technical expertise, and strong leadership skills, Michael Schelle is well-positioned to continue making a significant impact in the biotech industry. As the Executive Vice President at Remedy Plan Therapeutics, he is committed to driving innovation, fostering collaboration, and promoting sustainable growth within the organization and the broader life sciences ecosystem.
